196 related articles for article (PubMed ID: 35008338)
1. E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors.
Decourtye-Espiard L; Bougen-Zhukov N; Godwin T; Brew T; Schulpen E; Black MA; Guilford P
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008338
[TBL] [Abstract][Full Text] [Related]
2. Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells.
Bougen-Zhukov N; Nouri Y; Godwin T; Taylor M; Hakkaart C; Single A; Brew T; Permina E; Chen A; Black MA; Guilford P
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31540244
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib.
Bougen-Zhukov N; Decourtye-Espiard L; Mitchell W; Redpath K; Perkinson J; Godwin T; Black MA; Guilford P
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406381
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Godwin TD; Kelly ST; Brew TP; Bougen-Zhukov NM; Single AB; Chen A; Stylianou CE; Harris LD; Currie SK; Telford BJ; Beetham HG; Evans GB; Black MA; Guilford PJ
Gastric Cancer; 2019 Mar; 22(2):273-286. PubMed ID: 30066183
[TBL] [Abstract][Full Text] [Related]
6. Merging perspectives: genotype-directed molecular therapy for hereditary diffuse gastric cancer (HDGC) and E-cadherin-EGFR crosstalk.
Li D; Lo W; Rudloff U
Clin Transl Med; 2018 Feb; 7(1):7. PubMed ID: 29468433
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
8. Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking.
Brew T; Bougen-Zhukov N; Mitchell W; Decourtye L; Schulpen E; Nouri Y; Godwin T; Guilford P
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008266
[TBL] [Abstract][Full Text] [Related]
9. Germline E-cadherin mutations in familial lobular breast cancer.
Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
[TBL] [Abstract][Full Text] [Related]
10. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
11. CDH1 germline mutations and the hereditary diffuse gastric and lobular breast cancer syndrome: a multicentre study.
Benusiglio PR; Malka D; Rouleau E; De Pauw A; Buecher B; Noguès C; Fourme E; Colas C; Coulet F; Warcoin M; Grandjouan S; Sezeur A; Laurent-Puig P; Molière D; Tlemsani C; Di Maria M; Byrde V; Delaloge S; Blayau M; Caron O
J Med Genet; 2013 Jul; 50(7):486-9. PubMed ID: 23709761
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin-Deficient Cells.
Telford BJ; Chen A; Beetham H; Frick J; Brew TP; Gould CM; Single A; Godwin T; Simpson KJ; Guilford P
Mol Cancer Ther; 2015 May; 14(5):1213-23. PubMed ID: 25777964
[TBL] [Abstract][Full Text] [Related]
13. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells.
Beetham H; Chen A; Telford BJ; Single A; Jarman KE; Lackovic K; Luxenburger A; Guilford P
Sci Rep; 2019 Aug; 9(1):12511. PubMed ID: 31467357
[TBL] [Abstract][Full Text] [Related]
14. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice.
Graziano F; Humar B; Guilford P
Ann Oncol; 2003 Dec; 14(12):1705-13. PubMed ID: 14630673
[TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer in two families: A case report.
Feroce I; Serrano D; Biffi R; Andreoni B; Galimberti V; Sonzogni A; Bottiglieri L; Botteri E; Trovato C; Marabelli M; Ranzani GN; Bonanni B
Oncol Lett; 2017 Aug; 14(2):1671-1674. PubMed ID: 28789394
[TBL] [Abstract][Full Text] [Related]
16. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment.
Luo W; Fedda F; Lynch P; Tan D
Front Pharmacol; 2018; 9():1421. PubMed ID: 30568591
[TBL] [Abstract][Full Text] [Related]
17. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer.
Pinheiro H; Bordeira-Carriço R; Seixas S; Carvalho J; Senz J; Oliveira P; Inácio P; Gusmão L; Rocha J; Huntsman D; Seruca R; Oliveira C
Hum Mol Genet; 2010 Mar; 19(5):943-52. PubMed ID: 19965908
[TBL] [Abstract][Full Text] [Related]
19. Complementary molecular approaches reveal heterogeneous CDH1 germline defects in Italian patients with hereditary diffuse gastric cancer (HDGC) syndrome.
Molinaro V; Pensotti V; Marabelli M; Feroce I; Barile M; Pozzi S; Laghi L; Serrano D; Bernard L; Bonanni B; Ranzani GN
Genes Chromosomes Cancer; 2014 May; 53(5):432-45. PubMed ID: 24493355
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Male Lobular Breast Cancer in Hereditary Cancer Syndromes.
Carnevali I; Tedaldi G; Pensotti V; Sahnane N; Micello D; Rovera F; Sessa F; Tibiletti MG
Front Oncol; 2022; 12():891426. PubMed ID: 35686104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
